Browse Title Index

Issue Title
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in relapsed and refractory mantle cell lymphoma Abstract   PDF   HTML
C. Owen, J. Kuruvilla, A. Christofides
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in untreated chronic lymphocytic leukemia Abstract   PDF   HTML
C. Owen, C. Toze, A. Christofides
Vol 26, No 4 (2019) Updates from the 2019 American Society of Clinical Oncology and European Hematology Association annual meetings: a Canadian perspective on high-risk cytogenetics in multiple myeloma Abstract   PDF   HTML
R. LeBlanc, K. Song, D. White, A. Christofides, S. Doucette
Vol 24, No 2 (2017) Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists Abstract   PDF   HTML
M.A. O'Brien, S. Dhesy-Thind, C. Charles, M. Hammond Mobilio, N.B. Leighl, E. Grunfeld
Vol 18, No 3 (2011) Uptake of novel medical therapies in the general population Abstract   PDF   HTML
C. M. Booth, B. Rapoport
Vol 22, No 1 (2015) Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer Abstract   PDF   HTML
F. Santos, A. Dragomir, W. Kassouf, E. Franco, A. Aprikian
Vol 26, No 2 (2019) U.S. prevalence of endocrine therapy–naïve locally advanced or metastatic breast cancer Abstract   PDF   HTML
A. P. Nunes, C. Liang, W. J. Gradishar, T. Dalvi, J. Lewis, N. Jones, E. Green, M. Doherty, J. D. Seeger
Vol 19, No 4 (2012) Use and delivery of granulocyte colony–stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy—single-centre experience Abstract   PDF   HTML
X. Zhu, N. Bouganim, L. Vandermeer, S. F. Dent, G. Dranitsaris, M. J. Clemons
Vol 22, No 2 (2015) Use of bevacizumab as a first-line treatment for metastatic breast cancer Abstract   PDF   HTML
L. Manso, F. Moreno, R. Márquez, B. Castelo, A. Arcediano, M. Arroyo, A.I. Ballesteros, I. Calvo, M.J. Echarri, S. Enrech, A. Gómez, R. González del Val, E. López-Miranda, M. Martín-Angulo, N. Martínez-Jañez, C. Olier, P. Zamora
Vol 23 (2016): Use of Cannabinoids in Cancer Care Use of cannabinoids in cancer care: palliative care Abstract   PDF   HTML
S.K. Aggarwal
Vol 21, No 4 (2014) Use of chemotherapy and radiofrequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 years Abstract   PDF   HTML
N. Boame, G. Gresham, D. Jonker, G. Martel, F. Balaa, T. Asmis
Vol 21, No 3 (2014) Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline Abstract   PDF   HTML
X. Kostaras, F. Cusano, G.A. Kline, W. Roa, J. Easaw
Vol 21, No 1 (2014) Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy Abstract   PDF   HTML
S.P. Krotneva, A. Ramjaun, K.E. Reidel, T. Eguale, N. Trabulsi, N. Mayo, R. Tamblyn, A.N. Meguerditchian
Vol 23, No 5 (2016) Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data Abstract   PDF   HTML
K. Tran, R. Rahal, M. Brundage, S. Fung, C. Louzado, M. Milosevic, J. Xu, H. Bryant
Vol 21, No 6 (2014) Use of pet in the management of non-small-cell lung cancer in Canada Abstract   PDF   HTML
E. Vorauer, C. Louzado, K. DeCaria, J. Hernandez, R. Rahal, J. Niu, G. Lockwood, H. Bryant
Vol 24, No 2 (2017) Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer Abstract   PDF   HTML
C. Kendell, K.M. Decker, P.A. Groome, M.L. McBride, L. Jiang, M.K. Krzyzanowska, G. Porter, D. Turner, R. Urquhart, M. Winget, E. Grunfeld, for the Canadian Team to Improve Community-Based Cancer Care Along the Continuum
Vol 21, No 3 (2014) Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer Abstract   PDF   HTML
M. Mathews, D. Ryan, V. Gadag, R. West
Vol 25, No 6 (2018) Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting Abstract   PDF   HTML
S. Nazha, S. Tanguay, A. Kapoor, M. Jewett, C. Kollmansberger, L. Wood, G. Bjarnason, D. Heng, D. Soulières, N. Reaume, N. Basappa, E. Lévesque, A. Dragomir
Vol 22, No 3 (2015) Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review Abstract   PDF   HTML
P.M. Ellis, N. Coakley, R. Feld, S. Kuruvilla, Y.C. Ung
Vol 22, No 1 (2015) Use of the word “cured” for cancer patients—implications for patients and physicians: the Siracusa charter Abstract   PDF   HTML
P. Tralongo, L. Dal Maso, A. Surbone, A. Santoro, U. Tirelli, V. Sacchini, C. Pinto, S. Crispino, F. Ferraù, G. Mandoliti, G. Tonini, A. Russo, D. Santini, A. Madeddu, V. Panebianco, S. Pergolizzi, D. Respini, C. Rolfo, M. Bongiovanni, F. De Lorenzo, C. Spatola, F. Di Raimondo, M. Terenziani, M. Peeters, C. Castoro
Vol 24, No 4 (2017) User survey of Nanny Angel Network, a free childcare service for mothers with cancer Abstract   PDF   HTML
L. Cohen, N. Schwartz, A. Guth, A. Kiss, E. Warner
Vol 22, No 5 (2015) Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma Abstract   PDF   HTML
A. Schiavi, J. Lavigne, R. Turcotte, L. Karsprzak, N. Dumas, G. Chong, C. Freeman, M. Alameldin, P. Galiatsatos, L. Palma, W.D. Foulkes
Vol 18, No 2 (2011) Using a positive self-talk intervention to enhance coping skills in breast cancer survivors: lessons from a community based group delivery model Abstract   PDF   HTML
R. Hamilton, B. Miedema, L. MacIntyre, J. Easley
Vol 24, No 6 (2017) Using family history forms in pediatric oncology to identify patients for genetic assessment Abstract   PDF   HTML
A. Hamilton, E. Smith, J. Hamon, E. Tomiak, M. Bassal, S.L. Sawyer
Vol 21, No 6 (2014) Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review Abstract   PDF   HTML
M. Smoragiewicz, J. Laskin, D. Wilson, K. Ramsden, J. Yee, S. Lam, T. Shaipanich, Y. Zhai, C. Ho
Vol 22, No 3 (2015) Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience Abstract   PDF   HTML
E. Baxter, L. Gondara, C. Lohrisch, S. Chia, K. Gelmon, M. Hayes, A. Davidson, S. Tyldesley
Vol 22, No 5 (2015) Using tablet-based technology in patient education about systemic therapy options for early-stage breast cancer: a pilot study Abstract   PDF   HTML
E.R. Morgan, K. Laing, J. McCarthy, F. McCrate, M.D. Seal
Vol 22, No 2 (2015) Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada Abstract   PDF   HTML
A.J. Coldman, N. Phillips, J. Brisson, W. Flanagan, M. Wolfson, C. Nadeau, N. Fitzgerald, A.B. Miller
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada Abstract   PDF   HTML
C. Popadiuk, C.L. Gauvreau, M. Bhavsar, C. Nadeau, K. Asakawa, W.M. Flanagam, M.C. Wolfson, A.J. Coldman, S. Memon, N. Fitzgerald, J. Lacombe, A.B. Miller
Vol 26, No 4 (2019) Utility of a chemotherapy toxicity prediction tool for older patients in a community setting Abstract   PDF   HTML
C. Mariano, R. Jamal, P. Bains, S. Hejazi, L. Chao, J. Wan, J. Ho
Vol 22, No 5 (2015) Utilization of magnetic resonance imaging in breast cancer screening Abstract   PDF   HTML
D. Lin, L. Moy, D. Axelrod, J. Smith
Vol 21, No 3 (2014) Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease Abstract   PDF   HTML
J.A. Broomfield, J.N. Greenspoon, A. Swaminath
Vol 15, No 5 (2008) Validation of Symptom Clusters in Patients with Metastatic Bone Pain Abstract   PDF
Stephanie Hadi, Liying Zhang, Amanda Hird, Eric de Sa, Edward Chow
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada Abstract   PDF   HTML
J. Lemieux, S. Audet
Vol 25, No 2 (2018) Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario Abstract   PDF   HTML
K.E. Brennan, S.F. Hall, T.E. Owen, R.J. Griffiths, Y. Peng
Vol 21, No 4 (2014) Venous thromboembolism in cancer patients: a call for more awareness Abstract   PDF   HTML
A. Delluc, M. Carrier
Vol 23, No 4 (2016) Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia Abstract   PDF   HTML
H. Sibai, J.T. Seki, T.Q. Wang, N. Sakurai, E.G. Atenafu, K.W.L. Yee, A.C. Schuh, V. Gupta, M.D. Minden, A.D. Schimmer, J.M. Brandwein
Vol 17, No 2 (2010) Vera Peters and the conservative management of early-stage breast cancer Abstract   PDF
D. H. Cowan
Vol 15, No 5 (2008) Vera Peters and the curability of Hodgkin's disease. Abstract   PDF
Donald Henry Cowan
Vol 19, No 6 (2012) Views of breast and colorectal cancer survivors on their routine follow-up care Abstract   PDF   HTML
R. Urquhart, A. Folkes, J. Babineau, E. Grunfeld
Vol 22, No 4 (2015) Views of family physicians about survivorship care plans to provide breast cancer follow-up care: exploration of results from a randomized controlled trial Abstract   PDF   HTML
M.A. O'Brien, E. Grunfeld, J. Sussman, G. Porter, M. Hammond Mobilio
2008: Presentations from the Integrating Wellness into Cancer Care Conference Visions on Wellness from a Single Large Academic Institution to a Provincial Plan Abstract   PPT Presentation
Bob Bell, Terry Sullivan
Vol 24, No 6 (2017) Wait times for diagnosis and treatment of lung cancer: a single-centre experience Abstract   PDF   HTML
C. Labbé, M. Anderson, S. Simard, L. Tremblay, F. Laberge, R. Vaillancourt, Y. Lacasse
Vol 22, No 5 (2015) Wait times for prostate cancer treatment and patient perceptions of care in Canada: a mixed-methods report Abstract   PDF   HTML
K. Tran, C. Sandoval, R. Rahal, G. Porter, R. Siemens, J. Hernandez, S. Fung, C. Louzado, J Liu, H. Bryant
Vol 20, No 6 (2013) Weakly hormone receptor– positive breast cancer and use of adjuvant hormonal therapy Abstract   PDF   HTML
C.M. Lin, J. Jaswal, T. Vandenberg, A. Tuck, M. Brackstone
Vol 17, No 4 (2010) Weathering storms: a cohort study of how participation in a mindfulness based stress reduction program benefits women after breast cancer treatment Abstract   PDF
R.H. Matousek, P.L. Dobkin
Vol 18, No 1 (2011) Weekly paclitaxel in ovarian cancer—the latest success story Details   PDF   HTML
A. Jain, B. Dubashi, K.S Reddy, P. Jain
Vol 22, No 6 (2015) Wellness Beyond Cancer Program: Building an effective survivorship program Abstract   PDF   HTML
M. Rushton, R. Morash, G. Larocque, C. Liska, S. Stoica, C. Degrasse, R. Segal
2008: Presentations from the Integrating Wellness into Cancer Care Conference Wellspring: An Important Part of Integrative Health Care Abstract   PPT Presentation
Presenter Morrison
Vol 17, No 6 (2010) What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer? Abstract   PDF
E. Yu, P. Tai, R. Malthaner, L. Stitt, G. Rodrigues, R. Dar, B. Yaremko, J. Younus, M. Sanatani, M. Vincent, B. Dingle, D. Fortin, R. Inculet
Vol 25, No 4 (2018) What characterizes cancer family history collection tools? A critical literature review Abstract   PDF   HTML
J.E. Cleophat, H. Nabi, S. Pelletier, K. Bouchard, M. Dorval
Vol 25, No 3 (2018) What do primary care providers think about implementing breast cancer survivorship care? Abstract   PDF   HTML
M. Luctkar-Flude, A. Aiken, M.A. McColl, J. Tranmer
Vol 26, No 2 (2019) What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer? Abstract   PDF   HTML
Y. J. Ko, M. Abdelsalam, P. Kavan, H. Lim, P. A. Tang, M. Vincent, R. Wong, M. Kish, S. Gill
Vol 20, No 2 (2013) What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer? Abstract   PDF   HTML
C. Cox, C.M. Holloway, A. Shaheta, S. Nofech-Mozes, F.C. Wright
Vol 19, No 2 (2012) What is the optimal management of dysphagia in metastatic esophageal cancer? Abstract   PDF   HTML
W.C. Hanna, M. Sudarshan, D. Roberge, M. David, K.A. Waschke, S. Mayrand, T. Alcindor, L.E. Ferri
Vol 19, No 6 (2012) What is the optimal management of dysphagia in metastatic esophageal cancer? Details   PDF   HTML
F. Cavallin, M. Scarpa, M. Cagol, R. Alfieri, C. Castoro
2008: Presentations from the Integrating Wellness into Cancer Care Conference What the Patient wants from the Healthcare Professional Abstract   PPT Presentation
Charlotte Schultz
Vol 24, No 5 (2017) What we learned in kindergarten: five tips for collaboration in oncology Abstract   PDF   HTML
A. Arnaout, A.A. Joy, M. Juliao, M. Clemons
Vol 24, No 3 (2017) When cancer hits the streets Abstract   PDF   HTML
K.I. Stajduhar, A. Mollison, D. Gleave, S.W. Hwang
Vol 23, No 5 (2016) When Impatience is a Virtue Abstract   PDF   HTML
N. Mills
Vol 20, No 1 (2013) When jurisdictional boundaries become barriers to good patient care Abstract   PDF   HTML
J. Stephen, K. Fergus, S. Sellick, M. Speca, J. Taylor-Brown, J. Turner, K. Collie, D. McLeod, A. Rojubally
Vol 26, No 3 (2019) When the oncologist becomes the patient Abstract   PDF   HTML
E. Aitini
Vol 24, No 4 (2017) When the patient is also a carer Abstract   PDF   HTML
E. Warner
Vol 20, No 1 (2013) When the tumour is not the culprit: avascular necrosis of the hip in a patient with castration-resistant prostate cancer Abstract   PDF   HTML
E. Chan, G. Chan, L. Ehrlich, P. Hull, H. Kreder, W. Chu, E. Chow, U. Emmenegger
Vol 24, No 4 (2017) Wherein the authors attempt to minimize the confusion generated by their study “Breast cancer mortality after a diagnosis of ductal carcinoma in situ” by several commentators who disagree with them and a few who don’t: a qualitative study Abstract   PDF   HTML
S.A. Narod, H. Ahmed, V. Sopik
Vol 22, No 5 (2015) White Abstract   PDF   HTML
S.B. Weiner
Vol 26, No 3 (2019) Whither palliative care? Abstract   PDF   HTML
C. L. Watt, J. Downar
Vol 26, No 4 (2019) Who cares? The impact on caregivers of suspected mining-related lung cancer Abstract   PDF   HTML
N. Lightfoot, L. MacEwan, L. Tufford, D. L. Holness, C. Mayer, D. M. Kramer
Vol 26, No 2 (2019) Why are we organizing another costing supplement in Current Oncology? Abstract   PDF   HTML
N. Mittmann
Vol 23 (2016): Use of Cannabinoids in Cancer Care Why I chose to use cannabis Abstract   PDF   HTML
L. Perrier
Vol 23, No 4 (2016) Will oncologists applaud the Paris Accord? Time to rethink global mega-conferences Abstract   PDF   HTML
C. Jacobs, A.A. Joy, M. Clemons
Vol 24, No 4 (2017) Women with cancer in low-income countries Abstract   PDF   HTML
S.A. Narod
Vol 16, No 5 (2009) Workplace support for employees with cancer Abstract   PDF
B. Nowrouzi, N. Lightfoot, K. Cote, R. Watson
Vol 22, No 6 (2015) Worth his weight in… Abstract   PDF   HTML
M.R. Chasen
Vol 22, No 1 (2015) Yoga in adult cancer: a pilot survey of attitudes and beliefs among oncologists Abstract   PDF   HTML
M.C. McCall, A. Ward, C. Heneghan
Vol 21, No 1 (2014) “Bored out of my gourd”: a cancer survivor’s return-to-work experience Abstract   PDF   HTML
T. Morrison, R. Thomas
Vol 15, No 1 (2008) “Crack lung and heart” presenting in a 65 year old man with NHL following chemotherapy Abstract   PDF
Richard Van Der Jagt, Gonzalo Alvarez
Vol 16, No 3 (2009) “This is a kind of betrayal”: A Qualitative Study of Disability after Breast Cancer Abstract   PDF
Roanne Leigh Thomas-MacLean, Anna Towers, Elizabeth Quinlan, Thomas Hack, Winkle Kwan, Baukje Miedema, Andrea Tilley, Paul Graham
1601 - 1678 of 1678 Items << < 12 13 14 15 16 17